January 2014

Dear shareholders and prospective shareholders,

In January, we disclosed that we expect to report 2013 revenue of approximately US$7,680,000. The anticipated revenue for the year would represent a 12 percent increase compared to 2012 revenue.

That preliminary, unaudited 2013 revenue number means our fourth quarter, 2013 revenue estimates exceed US$2,000,000. This is the first time in CRH’s history that quarterly revenue should surpass that dollar value.

New Corporate Presentation

In 2013, we launched our new corporate website (http://investors.crhsystem.com/). Last month, we followed that up with the launch of a new corporate presentation; we use the presentation as a tool to help communicate the CRH story to the Street – if readers are interested in learning about how we present CRH Medical in conjunction with the presentation, please feel free to call me and I’d be pleased to go through it.

Much of the key information in the presentation is similar to what was in our older presentation, but the look and feel is now in-line with the website.

Readers can view the presentation by clicking the following link:

http://investorscrh.wpengine.com/wp-content/uploads/Winter-2014.pdf

 

Gastroenterology Conferences

This past month, CRH attended two gastroenterology conferences:

The first was a regional meeting, held by the American Gastroenterological Association (AGA) in Miami Beach, FL. This was our second time attending the meeting and proved to be extremely worthwhile.

The second conference we attended was the ACG Board of Governors/ASGE Best Practices Course held in Las Vegas, NV. This is a regular meeting for us as it brings in gastroenterologists from across the U.S.

As always, we were able to meet with a number of physicians already using our technology – providing both clinical and operational tips where possible, as well as speak with new GIs about introducing the procedure to their patients for the first time.

February Non-Deal Marketing

Later this month, we’ll be in Montreal and Toronto for a non-deal roadshow with investors. The last time we were in Montreal, investors were very receptive to the CRH story so our goal this time around is to try and keep that momentum going.

We have also made a lot of progress in Toronto the past two years. This month, we’ll be focused on meeting new buyside accounts while moving more established relationships forward.
We look forward to sharing the February edition of the CRH Investor Bulletin with you, and as always, we appreciate your interest and support.

Adam Peeler
Media and Investor Relations
TMX Equicom
416.815.0700 x 225
apeeler@tmxequicom.com

We're a stable, profitable company respected by both patients and physicians. Learn more »